Skip to main content
ACON
NASDAQ Industrial Applications And Services

Aclarion Seeks Shareholder Approval for Significant Equity Plan Expansion, Authorizing 18.56% Potential Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$3.37
Mkt Cap
$7.692M
52W Low
$2.34
52W High
$12.03
52W Position info
44% above low
Off High info
72% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

ACON sits 44% above its 52-week low of $2.34.

Summary

Aclarion, Inc. filed a definitive proxy statement for its annual meeting, seeking shareholder approval to significantly expand its 2022 Equity Incentive Plan, which could result in substantial future dilution.


Key Events · Corporate Governance and Compliance · ACON

  • Annual Meeting Scheduled

    The company will hold its Annual Meeting of Stockholders on June 4, 2026, to vote on several proposals.

  • Significant Equity Plan Expansion Proposed

    Shareholders are asked to approve an amendment to the 2022 Equity Incentive Plan, increasing the total shares reserved for issuance by 457,026, from 42,974 to 500,000 shares.

  • Substantial Potential Dilution

    If all newly authorized shares were issued, it would represent a potential dilution of approximately 18.56% to the current 2,462,250 outstanding shares.

  • Increased Individual Grant Limits

    The annual per-participant grant limit for equity awards would be raised from 52 shares to 250,000 shares, providing significantly more flexibility for future grants.


Analysis · ACON · Industrial Applications And Services

Aclarion, Inc. is seeking shareholder approval to substantially amend its 2022 Equity Incentive Plan. The proposed amendment would increase the total shares reserved for issuance by 457,026, bringing the new total to 500,000 shares. If all these newly authorized shares were issued, it would represent a potential dilution of approximately 18.56% to the current outstanding shares. Additionally, the annual per-participant grant limit for equity awards would significantly increase from 52 to 250,000 shares. While the company states this is necessary to attract and retain key personnel, this substantial potential dilution presents a negative signal, especially coming shortly after the company announced a $2.5 million share repurchase program on April 22, 2026, creating conflicting signals regarding capital allocation.

At the time of this filing, ACON was trading at $3.37 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.7M. The 52-week trading range was $2.34 to $12.03. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ACON - Latest Insights

ACON
Jun 09, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.35
Real-time Price: $2.13 info
Change: -$1.22 (-36%) info
Market Cap: $5.245M info
ACON
Jun 08, 2026, 7:05 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $3.53
Real-time Price: $2.13 info
Change: -$1.40 (-40%) info
Market Cap: $5.245M info
ACON
Jun 04, 2026, 4:49 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.53
Real-time Price: $2.13 info
Change: -$1.40 (-40%) info
Market Cap: $5.245M info
ACON
Jun 01, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.43
Real-time Price: $2.13 info
Change: -$1.30 (-38%) info
Market Cap: $5.245M info
ACON
May 28, 2026, 2:50 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $3.39
Real-time Price: $2.13 info
Change: -$1.26 (-37%) info
Market Cap: $5.245M info